AMSBIO is a specialist life science company offering an extensive portfolio of Poly (ADP-ribose) polymerase (PARP) isozymes. In addition, AMSBIO also offer assay kits, inhibitors, recombinant histone substrates and screening / profiling services for over 10 different PARP’s. Poly (ADP-ribose) polymerase (PARP) is a family of proteins that transfer ADP-ribose units from NAD+ onto target […]
–Joining forces for single-cell research excellence– PLEASANTON, CA.—10x Genomics, Inc., a company focused on accelerating genomic discovery, today announced that it has joined the Corporate Partnership Program of the European Molecular Biology Laboratory (EMBL), one of the world’s leading research institutions. “As a leader in single cell genomics, 10x Genomics is investing in institutional training […]
CE-IVD labeled PAXgene® Blood ccfDNA tube will be available in Western Europe FRANKLIN LAKES, N.J. and EYSINS, Switzerland — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the commercial availability of the CE-IVD marked PAXgene® Blood ccfDNA tube within the European Economic Area and Switzerland (Western Europe). The plastic blood collection tube, which includes […]
Real Endpoints plays 3rd party role introducing parties, helping craft structure, and will provide all analytics and financial reconciliation SAN DIEGO, WELLESLEY, Mass. and WESTPORT, Conn. — Illumina, Inc. and Harvard Pilgrim Health Care announced on February 1 a major new value-based contract (VBC) – one of the first of its kind between a […]
Patents in South Korea and Israel cover integration of an external DNA sequence into the chromosome of eukaryotic cells Merck continues to support research with genome editing under careful ethical and legal standards Merck to license its CRISPR-related patents to interested parties Darmstadt, Germany – Merck, a leading science and technology company and leader in genome editing, […]
Illumina and Genomics England partnership sequences 50,000 genomes The United Kingdom’s pioneering 100,000 Genomes Project has reached a major milestone by sequencing 50,000 genomes. Of those 50,000 genomes sequenced so far, 8,000 are for cancer patients and 42,000 for rare diseases. Breast, brain, colorectal, lung, prostate and renal are among those cancers to have […]
GenomeNext and Genomenon Partner to Speed Variant Curation for Whole Exome and Whole Genome Analysis ANN ARBOR, MI — GenomeNext, LLC announced today that it has embedded Genomenon’s Mastermind search results in its Olympus Platform to simplify and accelerate variant curation for genomic analysis. Efficacious variant interpretation is a critical but challenging requirement to translate genomics […]
— Patents in South Korea and Israel cover integration of an external DNA sequence into the chromosome of eukaryotic cells — MilliporeSigma continues to support research with genome editing under careful ethical and legal standards — MilliporeSigma to license CRISPR-related patents to interested parties BURLINGTON, Mass. — MilliporeSigma, a leader in genome editing, today announced that the Korean Intellectual Property Office […]
A highly versatile and customizable automation solution for budget and space constrained laboratories RADNOR, Pennsylvania — VWR, acquired by Avantor in 2017 as a wholly-owned subsidiary and leading global provider of product and service solutions to laboratory and production customers, announced today it has reached an agreement with Hamilton Bonaduz AG, a leading provider in the design […]
The U.S. International Trade Commission (USITC) has voted to institute an investigation of certain microfluidic systems and components thereof and products containing same. The products at issue in the investigation include microfluidic cartridges, reagents, and devices for preparing samples for sequencing. The investigation is based on a complaint filed by 10X Genomics, Inc., of Pleasanton, […]
Pay Invoice
Latest Blogs
-
Laboratory Tool Companies’ Dividends Show Stability
September 29, 2026 10:14 am
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.

